Načítá se...
Biomarkers predictive of survival and response to immune checkpoint inhibitors (ICI) in melanoma
Immunotherapy has revolutionized the treatment of melanoma. Targeting of the immune checkpoints cytotoxic T-lymphocyte-associated protein 4 and programmed cell death protein 1 has led to improved survival in a subset of patients. Unfortunately, the use of immune checkpoint inhibitors is associated w...
Uloženo v:
| Vydáno v: | Am J Clin Dermatol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6994371/ https://ncbi.nlm.nih.gov/pubmed/31602560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40257-019-00475-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|